Cross-sectional study reveals insufficient knowledge in physicians about hepatitis b-delta, suggesting training needs.
Context and objectif. Hepatitis B-Delta is a serious disease due to its rapid progression to cirrhosis or liver cancer. The present study assessed the level of knowledge of physicians in Kinshasa about hepatitis B-Delta, an essential step for better patient care. Methods. An analytical cross-sectional study was conducted in 2024 among 155 physicians in Kinshasa on their knowledge of hepatitis B-Delta (screening, diagnosis, fibrosis assessment, and treatment). A logistic regression model was used to identify factors associated with knowledge. The significance level was 5%. Results. The presence of the HbS antigen for screening is recognized by 59.3% of providers. Fibrosis assessment by Fibroscan is still requested by 55.8% of providers. Viral RNA positivity and viral load reduction as an indication and therapeutic objective were recognized in 25.4% and 59.5%, respectively. Younger physicians, general practitioners, internists/infectious disease specialists, and general hospitals are less likely to be aware of hepatitis D treatment, compared to providers familiar with the diagnostic biomarker. Conclusion. Physicians in Kinshasa have insufficient knowledge of hepatitis B-Delta, hence the need to strengthen professional training to improve Hepatitis B-Delta management. Received: February 26th, 2025 Accepted: June 12th, 2025 https://dx.doi.org/10.4314/aamed.v18i4.16
No takes yet. Share an insight, caveat, or question.
Ngele et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: